[an error occurred while processing this directive]

Construction and verification of a nomogram model for unplanned disembarkation due to clotting in cardiopulmonary bypass line in patients undergoing maintenance hemodialysis

  • WU Hai-Fang
Expand
  • Blood Purification Center, The Second Hospital of Shaoxing, Zhejiang Province, Shaoxing 312000, China

Received date: 2024-01-04

  Revised date: 2024-09-13

  Online published: 2024-12-12

Abstract

Objective  To investigate the influential factors of unplanned disembarkation due to clotting in cardiopulmonary bypass line in maintenance hemodialysis (MHD) patients, and to establish a nomogram model of unplanned disembarkation due to clotting in cardiopulmonary bypass line in MHD patients and to validate the nomogram.  Methods  The MHD patients treated in the General Hospital of Shaoxing Second Hospital from April 2022 to June 2023 were retrospectively studied. They were divided into modeling group and validation group with the ratio of 7:3. The clinical data of the modeling group were collected and were then divided into coagulation subgroup and non-coagulation subgroup according to the presence or absence of clotting in cardiopulmonary bypass line. By comparing the clinical data of the two subgroups, multivariate logistic regression was used to analyze the risk factors for clotting in cardiopulmonary bypass line in the MHD patients, and a nomogram model of clotting in cardiopulmonary bypass line in MHD patients was established and validated.  Results  A total of 286 patients were recruited as the study subjects. They were divided into modeling group (n=200) and verification group (n=86) with the ratio of 7:3. The modeling group were divided into coagulation subgroup (n=38) and non-coagulation subgroup (n=162). The incidence of clotting in cardiopulmonary bypass line in MHD patients was 19%. Hypotension (χ2=4.630, P=0.031), prothrombin time (t=2.392, P=0.018), platelet count (t=3.090, P=0.002), hemodialysis for the first time (χ2=4.935, P=0.026), anticoagulation method (χ2=8.546, P=0.014), treatment time (<8h/d, 8-16h/d, >16h/d) (χ2=9.497, P=0.009), blood flow velocity (<200ml/min, ≥200ml/min) (χ2=5.194, P=0.023) and health education before dialysis (χ2=6.991, P=0.008) were statistically different between the two subgroups. Multivariate logistic regression showed that hypotension (OR=3.160, 95% CI: 1.182~8.447, P=0.022), platelet count (OR=1.081, 95% CI: 1.049~1.115, P<0.001), hemodialysis for the first time (OR=3.354, 95% CI: 1.202~9.359, P=0.021), no anticoagulation used (OR=5.845, 95% CI:1.697~20.132, P=0.005), and lack of health education (OR=6.524, 95% CI: 2.322~18.330, P<0.001) were the independent risk factors for clotting in cardiopulmonary bypass line; longer prothrombin time (OR=0.378, 95% CI:0.261~0.547, P<0.001) and blood flow velocity ≥200 ml/min (OR=0.226, 95% CI:0.081~0.625, P=0.004) were the protective factors for clotting in cardiopulmonary bypass line. For verification of the nomogram, the area under ROC curve was 0.891 (95% CI: 0.835~0.947), a better discrimination ability was identified, the maximum approximate entry value was 0.641, the sensitivity was 0.789, and the specificity was 0.852. The theoretical value of calibration curve was in better agreement with the actual value.  Conclusion  This nomogram model of unplanned disembarkation caused by clotting in cardiopulmonary bypass line in MHD patients shows a better efficiency, and provides a reference for clinical practice. 

Cite this article

WU Hai-Fang . Construction and verification of a nomogram model for unplanned disembarkation due to clotting in cardiopulmonary bypass line in patients undergoing maintenance hemodialysis[J]. Chinese Journal of Blood Purification, 2024 , 23(12) : 952 -956 . DOI: 10.3969/j.issn.1671-4091.2024.12.015

References

[1]张晋才,张锋,冯颖博,等.终末期肾病合并恶性肿瘤血透患者心理健康、生存质量与应对方式现状及其相关性分析[J].肿瘤预防与治疗,2022,35(12):1098-1102.
[2]韩苗苗,袁建军,申凯凯,等.基于射频信号全息血管硬度分析评价终末期肾病合并高尿酸血症患者颈动脉弹性[J].中国医学影像技术,2022,38(05):684-688.
[3]杨雅景,郑娜.时效性激励理论的健康教育在维持性血液透析患者体重管理中的应用研究[J].中国健康教育,2022,38(04):367-370.
[4]宋蓉蓉,何恩晓,李娜娜.分阶段教育联合分级随访在尿毒症维持性血液透析患者中的应用[J].河南医学研究,2022,31(11):2097-2100.
[5]王质刚.血液净化学[M].4版.北京:北京科学技术出版社,2016:535-536.
[6]Chaudhuri S, Larkin J, Guedes M, et al. Predicting mortality risk in dialysis: Assessment of risk factors using traditional and advanced modeling techniques within the Monitoring Dialysis Outcomes initiative. Hemodial Int. 2023 Jan;27(1):62-73.
[7]陈香美.血液净化标准操作规程[M].北京:人民卫生出版社,2021.
[8]张朝平,张永红,王园园.血液透析器凝血的原因分析及对策[J].基层医学论坛,2018,22(03):430-431.
[9]徐金艳.血液透析患者非计划性下机情况及影响因素分析[J].中国临床护理,2023,15(01):44-46+50.
[10]水光兴,邹峰,贺丹,等.简化枸橼酸抗凝在血液透析高危出血倾向患者中的临床应用研究[J].中国中西医结合肾病杂志,2021,22(03):237-239.
[11]朱旻霞,张伟明,倪兆慧,等.维持性血液透析患者透析期血压波动与透析相关并发症的相关性分析[J].上海交通大学学报(医学版),2020,40(04):484-488.
[12]付平,唐万欣,崔天蕾.连续性肾脏替代治疗的临床应用进展[J].中国实用内科杂志,2006(06):411-413.
[13]张仲华,曾铁英,徐蓉,等.无抗凝连续性肾脏替代治疗非计划性下机相关因素分析[J].护士进修杂志,2019,34(18):1633-1639.
[14]Ginel-Mendoza L, Hidalgo-Natera A, Reina-Gonzalez R, et al. Efficacy of a joint didactic intervention using the Junta De Andalucía School for Patients method to control prothrombin time in patients taking anticoagulants: protocol for a randomized controlled trial. Trials. 2021 Jan 11;22(1):45.
[15]王海波,李克鹏,徐丽娟,等.重症合并急性肾损伤患者持续静脉-静脉血液透析滤过治疗时滤器凝血预测模型的建立与评价[J].潍坊医学院学报,2019,41(01):52-54+74.
Outlines

/

[an error occurred while processing this directive]